Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways

Publication date: Available online 19 June 2021Source: Journal of EthnopharmacologyAuthor(s): Chong Zhang, Lili Li, Shu Hou, Zhenghao Shi, Wenjing Xu, Qin Wang, Yinghao He, Yongfang Gong, Zhirui Fang, Yan Yang
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research